MedPath

A novel surgical technique for preventing pancreatic leakage after attaching the pancreas to the small intestine

Not Applicable
Conditions
Periampullary tumors
Cancer
Malignant neoplasm of pancreas
Registration Number
ISRCTN59731654
Lead Sponsor
Shenjing Hospital of China Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
All
Target Recruitment
390
Inclusion Criteria

1. Periampullary tumors indicated by at least two imaging examinations or pathological biopsy before surgery
2. =18 years of age
3. Provision of written informed consent by patients or their legal guardians

Exclusion Criteria

1. Extensive tumor metastasis
2. Abnormal blood coagulation
3. Renal dysfunction (creatinine >250 µmol/L)
4. Chronic liver disease
5. History of radiation therapy
6. American Society of Anesthesiologists (ASA) class IV-V
7. Life expectancy <48 hours
8. Lactating or pregnant women
9. Participation in other drug clinical trials

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of pancreatic fistula within 30 days after surgery (defined as an abdominal drain or incision output of fluid with an amylase level > 3 times the upper limit of institutional normal serum amylase activity for 3 days)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath